News

BioBridge offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the Social Media enthusiast, BioBridge Global is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also visit the official BioBridge Global blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

  • 
Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility
Please contact: 
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org
 

Recent News Articles

October 14, 2014

The ongoing Ebola outbreak in West Africa, which has now reached the United States and specifically Texas, has raised questions about the safety of blood donation and the blood supply. 

Dr. Rachel Beddard, BioBridge Global medical director, shares these important facts to keep in mind:

The South Texas Blood & Tissue Center, which is highly regulated by the Federal Drug Administration and other agencies, already safeguards our blood supply by requiring extra screening for potential donors who:

Present with any signs of illness. Symptoms include:

October 13, 2014

BioBridge Global (BBG), has selected Dr. Samantha Gomez Ngamsuntikul to be associate medical director for its subsidiaries the South Texas Blood & Tissue Center, QualTex Laboratories and GenCure. BioBridge Global CEO Linda Myers made the announcement today.

Gomez is a graduate of Texas Tech University, and her medical degree is from the University of Texas Health Science Center at San Antonio. She served her clinical residency at the University of Texas Medical Branch in Galveston and most recently was a transfusion medicine fellow at Stanford University Medical Center.

October 6, 2014

BioBridge Global (BBG), a nonprofit organization, and StemBioSys Inc. (SBS), a development-stage biomedical company in the emerging field of stem cell and regenerative medicine, are pleased to announce the grand opening of a new pilot manufacturing laboratory on the BBG campus.

In a collaboration agreement, BBG constructed lab space inside its headquarters building for use by StemBioSys, which will conduct research and product development activities using its patented procedures involving various types of adult stem cells. StemBioSys was founded in 2010 to develop technology, first created at the University of Texas Health Science Center – San Antonio (UTHSC) by SBS cofounder Dr. Xiao-Dong Chen, that enables the isolation and expansion of stem cells for medical research, diagnostic and therapeutic applications.

September 25, 2014

Dear Committed Lifesavers, 

We are calling on all blood donors with type A or O blood types to donate today! We are currently experiencing a high usage of these blood types due to the lifesaving treatment of area trauma and transplant patients. These are your donations hard at work, but more donors are still needed to replenish the community blood supply. This ensures hospitals have this resource when needed by other patients.

We encourage you to call us to set up your next appointment and/or check your donation eligibility. Please call 210-731-5590 or 800-292-5534 ext. 3500 or visit donatingforlife.org to schedule your appointment today!

September 23, 2014

On Sept. 8, 2014, St. David’s Women’s Center of Texas, located on the campus of St. David’s North Austin Medical Center, joined the Texas Cord Blood Bank’s (TCBB) cord blood collection program, making it a certified cord blood collection site. The TCBB, housed on the South Texas Blood & Tissue Center’s San Antonio campus, is a nonprofit program established in 2001 to collect umbilical cord blood, which can benefit patients—usually children—suffering from a number of potentially fatal diseases.

Pages